Trialect

Active

Biological Threat Reduction with Global Partners Broad Agency Announcement (BAA)

Department of Defense

The Defense Threat Reduction Agency (DTRA) Cooperative Threat Reduction (CTR) Biological Threat Reduction Program (BTRP) protects the United States, its Armed Forces, and our allies from biological threats by strengthening the capabilities of partner nations and the international community to prevent, detect, and prepare for disease outbreaks. BTRP supports international health security efforts to address diseases caused by U.S. Biological Select Agents (https://www.cdc.gov/selectagent/SelectAgentsandToxinsList.html), pathogens of pandemic potential, and emerging (and reemerging) infectious diseases. BTRP achieves its mission through collaboration with partner countries and the international community to minimize the threat of deliberate, accidental, and natural infectious disease outbreaks through enhanced detection, diagnosis, and reporting capabilities and biosecurity and biosafety measures. This Broad Agency Announcement (BAA) is an extramural endeavor that seeks to bring funding to biosurveillance studies that support biosecurity and biosafety (BS&S) capability building, in-country partnerships, and other needs appropriate to meet BTRP’s mission interests.

BTRP utilizes international engagements to promote science and technical collaborations with partner nations, regional and international organizations, and the global scientific community to foster and maintain ethical, constructive, and sustainable partnerships that address health security threats. In addition to increasing the knowledge and mitigation of risks posed by potential disease causing pathogens and approaches that build effective capacities and capabilities to reduce those risks, these projects are intended to develop strong international relationships through technical assistance that will enhance the ability of partner nations to contribute to global disease awareness and improve their domestic public health posture. Scientific studies evaluated and awarded through the BAA are one part of comprehensive country and regional engagements BTRP develops and maintains. Projects are designed to be relevant, cooperative, impactful, and contributory to enduring capabilities. There is a strong preference for science projects that are multi-sectoral/multi-institutional, build upon prior BTRP investments, and facilitate cooperation and transparency with local, national, regional, and/or international partners. Additionally, BTRP encourages that projects supported through the BAA be coordinated with activities from other U.S. government, academic, and international organizations programs.

This BAA is open continuously from 29 April 2024 through 28 April 2029 . Submissions aligning to the BTRP mission, general topic areas, and LOEs may occur at any time this BAA is in effect. Applicants should take care to note requirements and timelines for submitting Abstracts, White Papers, and Full Proposals.

Specialties

International Opportunities

Medical - Basic Science

Social Sciences

Medical

Medical - Translational

Eligibility Requirements

Abstracts, White Papers, and Full Proposals submitted for the BAA will be considered from the following U.S. and foreign institutions as follows:
• Accredited degree-granting colleges, universities, and academic institutions.
• Industrial and commercial entities, including small businesses.
• Not-for-profit entities with a portfolio predominantly in research and foreign government laboratories. Proof of 501(c)(3) status from the Internal Revenue Service may be required. For foreign-based establishments entirely based outside the U.S. and/or its territories, proof of not-for-profit status may be required. Foreign based government laboratory equivalents include (but are not limited to) those residing in a country’s Ministry of Defense, Ministry of Health, Ministry of Agriculture, Ministry of Education and Science and Food Safety Agencies.